Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2025-12-25 @ 4:53 AM
NCT ID:
NCT00328718
Eligibility Criteria:
Inclusion criteria:
* Diagnosis of asthma for at least 6 months (per American Thoracic Society \[ATS\] definition).
* Best forced expiratory volume in one second (FEV1) between 55% and 80% of predicted normal.
* More than or 12% FEV1 reversibility following inhalation of salbutamol.
* Must also be symptomatic on short-acting beta-agonists.
* Must not have used inhaled corticosteroids over the previous month or LTRAs (Leukotriene antagonists)over the previous 2 weeks.
Exclusion criteria:
* Hospital admission for asthma within 3 months prior to Visit 1.
* Sinus, middle ear, oropharyngeal, upper or lower respiratory tract infections within two weeks immediately preceding Screening Visit 1.
* Oral or parenteral steroid therapy in the last 12 weeks, or more than 3 courses in the last 6 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
14 Years
Study:
NCT00328718
Study Brief:
Protocol Section:
NCT00328718